N
SLXP

Nuveen’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Nuveen’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,843
Closed -$4.47M – 1703
2015
Q1 		$4.47M Sell
25,843
-138
-0.5% -$20.3K 0.02% 550
2014
Q4 		$2.99M Sell
25,981
-16
-0.1% -$1.94K 0.02% 700
2014
Q3 		$4.06M Sell
25,997
-172,194
-87% -$25M 0.03% 602
2014
Q2 		$24.4M Sell
198,191
-73,522
-27% -$8.13M 0.15% 177
2014
Q1 		$28.2M Sell
271,713
-51,147
-16% -$5.24M 0.17% 140
2013
Q4 		$29M Buy
322,860
+58,588
+22% +$4.67M 0.19% 149
2013
Q3 		$17.7M Buy
264,272
+173,841
+192% +$12M 0.11% 242
2013
Q2 		$5.98M Buy
+90,431
New +$5.17M 0.04% 459

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Nuveen's SLXP Position: Q2 2015 in Review

Nuveen sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 25,843 shares — an estimated $4.47M sold.

Nuveen first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $29M in Q4 2013. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Nuveen reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Nuveen sold 25,843 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $4.47M.
  • Nuveen first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Nuveen's SALIX PHARMACEUTICALS LTD DEL position peaked at $29M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Nuveen's 13F filing for Q2 2015, filed 14 Aug 2015.